calendar
236 catalysts · 3,921 phase readout · 2,141 8k filing · 277 earnings · 172 phase 2 completion · 133 drug shortage · 109 grant
next 91 dayslessmore
MonWedFri
236 catalysts · 3,921 phase readout · 2,141 8k filing · 277 earnings · 172 phase 2 completion · 133 drug shortage · 109 grant
No description on file. Bork keeps sniffing.
No description on file. Bork keeps sniffing.
No description on file. Bork keeps sniffing.
No description on file. Bork keeps sniffing.
No description on file. Bork keeps sniffing.
No description on file. Bork keeps sniffing.
No description on file. Bork keeps sniffing.
No description on file. Bork keeps sniffing.
No description on file. Bork keeps sniffing.
No description on file. Bork keeps sniffing.
No description on file. Bork keeps sniffing.
No description on file. Bork keeps sniffing.
No description on file. Bork keeps sniffing.
No description on file. Bork keeps sniffing.
No description on file. Bork keeps sniffing.
No description on file. Bork keeps sniffing.
No description on file. Bork keeps sniffing.
No description on file. Bork keeps sniffing.
No description on file. Bork keeps sniffing.
No description on file. Bork keeps sniffing.
No description on file. Bork keeps sniffing.
No description on file. Bork keeps sniffing.
No description on file. Bork keeps sniffing.
No description on file. Bork keeps sniffing.
No description on file. Bork keeps sniffing.
No description on file. Bork keeps sniffing.
No description on file. Bork keeps sniffing.
No description on file. Bork keeps sniffing.
No description on file. Bork keeps sniffing.
No description on file. Bork keeps sniffing.
No description on file. Bork keeps sniffing.
This page contains notices of advisory committee meetings. Refer to the individual meeting link below for more information on the anticipated format of each meeting. For previous years' advisory committee calendars, see the FDA Archive.
Prescription Drug User Fee Act goal date of July 17, 2026
action date of January 4, 2027
Sponsor: ABBVIE. Form: IMPLANT. Route: INTRAVITREAL
Sponsor: NOVARTIS. Form: TABLET. Route: ORAL